“…GCs reach the nuclei of many cell types by forming a complex after binding to a specific cytoplasmic receptor protein ( Figure 1 ). There, they induce the synthesis of tyrosine-aminotransferase and tryptophan pyrrolase, 11 which exerts a number of tissue-specific and systemic effects as follows: - reduction of chemotaxis, a pivotal process in inflammatory reactions and neutrophil activity, 12
- reduction of vessel wall permeability, leading to less edema formation, exudation and migration of inflammatory cells, 10
- reduction of antigen phagocytosis, 10
- increase in hepatic gluconeogenesis, 10
- downregulation of peripheral protein metabolism but enhanced hepatic protein synthesis, 10
- alanine release from the musculature (increased plasma levels); this gluconeogenesis substrate surplus induces pancreatic glucagon secretion (from A cells) and subsequent hyperglucagonemia, 10 and
- fatty acid mobilization from subcutaneous storage (mainly in the extremities) and blockage of lipogenesis at these sites. In contrast, lipogenesis is increased in abdominal fat tissue.
…”